Numerai quietly slurps another $1.2M of NMR, now $3.2M deep in its own stash 🧠

San Francisco-based hedge fund Numerai has completed a third open-market purchase of its native token Numeraire ($NMR), acquiring an additional $1.2 million worth and bringing total repurchases to $3.2 million within roughly one year. The buyback, executed through Coinbase Institutional at or near the bid price over several weeks to minimize market impact, had already been completed before being announced on July 17th, 2026. Prior to this latest purchase, approximately 3.1 million $NMR remained in Numerai's treasury, drawn down as the firm replenishes holdings used for staking incentives and tournament rewards distributed to data scientists.

The repurchases are tied to Numerai's staking system, in which contributors stake $NMR on their machine-learning models, earn additional $NMR when their predictions perform well on future market data, and lose it when they do not. Those staked signals feed the firm's Stake-Weighted Meta Model, which the company said continues to outperform Numerai's internal benchmark models, demonstrating the value of aligning incentives with predictive performance. $NMR is a fixed-supply Ethereum token capped at 11 million $NMR.

Since announcing its first strategic buyback in July 2025, Numerai's contributor network has expanded significantly, with active accounts more than doubling over the past year and submissions continuing to rise. The platform has added new infrastructure including Numerai Skills, Numerai Model Context Protocol (MCP), and Atomic Blockchain Staking, enabling increasingly autonomous participation by AI systems. The underlying hedge fund has also grown, with Numerai now managing approximately $700 million in assets, up from approximately $560 million at the end of 2025.

Numerai is a San Francisco-based hedge fund and data science platform founded in 2015 that aggregates stock-market predictions from thousands of global data scientists into a single Meta Model used to trade global equities. The company noted that past performance is not indicative of future results and that the announcement does not represent an offer to purchase or sell any security or the interests of any account managed by Numerai GP, LLC or its affiliates.